An external ventricular drain (EVD) and a ventriculoperitoneal (VP) shunt both move excess cerebrospinal fluid (CSF) out of the brain’s ventricles, but they serve fundamentally different roles. An EVD is a temporary, externally managed catheter used in acute emergencies, while a VP shunt is a surgically implanted, long-term device designed to manage chronic hydrocephalus for months, years, or a lifetime. The distinction matters for patients and families because the two devices carry different risk profiles, different day-to-day realities, and different decision points along the course of treatment.
Why the Brain Needs Fluid Drainage in the First Place
Your brain continuously produces cerebrospinal fluid inside hollow chambers called ventricles. This fluid cushions the brain and spinal cord, delivers nutrients, and carries away waste. Under normal conditions it circulates freely, getting absorbed back into the bloodstream at roughly the same rate it is produced. When something disrupts that balance, whether a tumor blocking a passageway, bleeding filling the ventricles, or impaired absorption after an infection, fluid backs up and pressure inside the skull climbs. That rising pressure can damage brain tissue quickly and is life-threatening if not relieved.1PubMed Central. Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases
In non-communicating hydrocephalus, the blockage sits somewhere within or just outside the ventricles. In communicating hydrocephalus, the obstruction lies farther along the circulation pathway, between the base of the brain and the sites where CSF is normally reabsorbed. Either way, continued fluid production can create dangerous swelling. When outflow is blocked, some fluid may seep through surrounding brain tissue as a partial safety valve, but that mechanism alone is not enough to prevent harm.2PubMed Central. Regulation of brain fluid volumes and pressures: basic principles, intracranial hypertension, ventriculomegaly and hydrocephalus Both an EVD and a VP shunt exist to solve this problem, just on very different timescales.
How an EVD Works
An EVD is essentially a thin catheter threaded through a small hole in the skull directly into one of the brain’s ventricles. The other end connects to an external drainage bag hung at the patient’s bedside. Gravity does most of the work: the bag is positioned at a specific height relative to the patient’s ear, and the height setting determines how much pressure must build before fluid drains. Raise the bag and less fluid drains; lower it and more flows out. That adjustability is one of the EVD’s greatest strengths in critical care.
Placement typically happens at the bedside, often by a neurosurgeon or neurointensivist using anatomical landmarks on the scalp, and it can be done under urgent conditions in an ICU. The device serves a triple purpose: it drains CSF and blood products to relieve dangerously high intracranial pressure, it provides continuous real-time pressure monitoring, and it can be used to deliver medications directly into the ventricles when needed.3PubMed Central. External ventricular drains: Management and complications That combination of drainage, monitoring, and drug delivery makes EVDs indispensable after events like subarachnoid hemorrhage, traumatic brain injury, and intraventricular hemorrhage.
Because the catheter exits the body, the patient is tethered to a bedside collection system and must remain in an intensive care unit. Every interaction with the drain, from zeroing the pressure transducer to flushing the line, carries infection risk. EVDs are designed as a bridge: they buy time while the underlying cause is treated, and they help clinicians decide whether the patient will ultimately need a permanent device.
How a VP Shunt Works
A VP shunt is an entirely internal system. A proximal catheter sits inside the brain’s ventricle, connected to a one-way valve placed beneath the scalp (usually behind the ear), which then leads to a long distal catheter tunneled under the skin down the neck and chest and into the abdominal cavity. Excess CSF drains into the peritoneum, where the body reabsorbs it naturally. The whole apparatus is invisible from the outside aside from a small bump where the valve sits under the scalp.
Unlike an EVD, placement is a formal surgical procedure done in an operating room under general anesthesia. Surgeons choose from several entry points on the skull, each with trade-offs in catheter positioning. In one single-center study, catheter tip placement in the intended ventricle ranged from about 60% to 90% depending on the entry point chosen, and revision rates varied accordingly, with one entry point showing a 30% revision rate and another as low as about 9%.4PubMed Central. Ventriculoperitoneal shunt entry points in patients undergoing shunt placement: A single-center study The use of image guidance during surgery can improve catheter placement accuracy, though it does not eliminate the risk of failure entirely.5PubMed. Reducing the risks of proximal and distal shunt failure in adult hydrocephalus: a shunt outcomes quality improvement study
The valve is the heart of the system. Modern VP shunts use programmable valves that allow a clinician to adjust the drainage pressure setting from outside the body using a magnetic tool, without any additional surgery. This is useful because a patient’s optimal drainage pressure can change over time, with activity levels, body position, or disease progression.
Valve Design and the Overdrainage Problem
One persistent engineering challenge with VP shunts is overdrainage. When a person stands up, gravity pulls CSF down through the long distal catheter much faster than intended, creating a siphon effect. This can lower intracranial pressure too much, causing headaches, subdural fluid collections, or collapsed ventricles. Antisiphon devices are built into many modern shunt systems to counteract this, and they come in several design families: diaphragm-based, gravity-based, and flow-reducing mechanisms.6PubMed Central. Antisiphon device: A review of existing mechanisms and clinical applications to prevent overdrainage in shunted hydrocephalic patients
Each type has quirks. Flow-reducing devices stay open all the time and deliver relatively stable flow, but they may not allow enough drainage when pressure spikes during sleep. Diaphragm devices respond to the patient’s position but are sensitive to external pressure on the scalp and to their exact placement relative to the skull. Gravity-based devices respond to the angle of the patient’s head. Research on gravitational devices has shown encouraging results overall.6PubMed Central. Antisiphon device: A review of existing mechanisms and clinical applications to prevent overdrainage in shunted hydrocephalic patients Programmable valves with antisiphon features are considered helpful for tall, thin patients who are particularly prone to siphoning, but these same valves must be used cautiously in obese patients, who face a higher risk of underdrainage instead.7PubMed Central. Shunt Devices for the Treatment of Adult Hydrocephalus: Recent Progress and Characteristics
Infection and Complication Risks Compared
Both devices carry infection risk, but the profiles differ. For EVDs, infection rates in a large study were about 2.2% within the first 30 days of placement, driven primarily by the same bacteria that live on the skin. CSF leaking around the catheter and skin breakdown at the insertion site were among the strongest predictors of infection, increasing the hazard dramatically. Prior brain surgery involving CSF diversion also raised risk substantially.8PubMed Central. Risk factors and outcomes associated with external ventricular drain infections A systematic review and meta-analysis across 48 studies found additional risk factors including the presence of bleeding in the ventricles, having a body-wide infection at the same time, catheter changes, bilateral drain placement, and duration of EVD use beyond seven days.9PubMed Central. Risk Factors for External Ventricular Drainage–Related Infection: A Systematic Review and Meta-analysis
Interestingly, whether duration beyond seven days independently raises infection risk is a point of debate. The single-center study cited above did not find a significant association between duration past one week and infection, while the meta-analysis pooling many institutions did. This discrepancy likely reflects variation in care bundles, insertion techniques, and definitions of infection across different hospitals. Clinicians weigh this uncertainty when deciding how long to keep an EVD in place.
How the EVD is managed, whether it drains continuously or is clamped and opened intermittently, also affects complications. In the only randomized trial comparing these two strategies in subarachnoid hemorrhage patients, continuous drainage was associated with an unacceptably high rate of drain malfunction and infection, to the point that the trial was stopped early for safety reasons.10PubMed Central. External Ventricular Drains After Subarachnoid Hemorrhage: Is Less More?
VP shunt complications unfold over a longer timeline. Because the device is permanent, failure can happen months or years after placement. The distal catheter in the abdomen can become blocked by omentum (the fatty apron of tissue in your belly), kink, disconnect, or migrate. In one analysis, distal slit-valve catheters had a notably higher rate of failure compared to conventional valve systems, with roughly a third of slit-valve shunts failing distally versus about 14% for standard designs.11PubMed Central. Ventriculoperitoneal Shunt Failure Due to Distal Peritoneal Catheter Kinking Shunt failure rates overall remain high enough that the field openly describes VP shunt outcomes as poor, and improving them is an active area of quality-improvement research.5PubMed. Reducing the risks of proximal and distal shunt failure in adult hydrocephalus: a shunt outcomes quality improvement study
When Patients Transition from EVD to VP Shunt
Not every patient with an EVD ends up needing a permanent shunt. The decision hinges on whether the brain can resume managing its own fluid once the acute crisis resolves. Clinicians test this by gradually raising the EVD drainage bag (making it harder for fluid to drain) and watching whether the patient’s intracranial pressure stays manageable. If it does, the EVD is eventually clamped and then removed. If pressure climbs whenever drainage is restricted, a permanent shunt is likely needed.
Predicting who will need that permanent device is an area of active research. In patients with intraventricular hemorrhage, the degree to which bleeding cleared and the size of certain ventricle structures after treatment were significant predictors. Patients whose hemorrhage shrank by more than 45% and whose temporal horn diameter stayed below 9 mm were less likely to need a permanent shunt.12PubMed. Prediction of Permanent Shunt Dependency in Patients with Intraventricular Hemorrhage: Outcomes of Early External Ventricular Drainage Weaning Protocol These kinds of predictive tools help clinicians avoid both premature shunt placement and unnecessary delays.
The weaning process itself matters. The only randomized trial comparing rapid versus gradual EVD weaning found that a faster approach reduced EVD days, ICU days, and overall hospital stay.10PubMed Central. External Ventricular Drains After Subarachnoid Hemorrhage: Is Less More? Faster weaning also means less time exposed to the ongoing infection risk of an external catheter.
ICP Monitoring Differences
One advantage EVDs hold over VP shunts is the ability to continuously monitor intracranial pressure. VP shunts work passively and silently; once implanted, there is no built-in way to measure the pressure inside the ventricles or verify that the shunt is functioning. Detecting VP shunt failure often relies on the return of symptoms like headaches, nausea, or altered consciousness, followed by imaging.
EVDs, by contrast, provide a real-time pressure readout as long as they are in place. However, EVD-based monitoring has limitations. In a pediatric study comparing EVD pressure readings with a separate intraparenchymal pressure sensor, about 73% of intracranial pressure crises were detected first by the separate sensor, and roughly half of those were missed entirely by the EVD monitor. The average delay between detection by the two methods was over 12 minutes.13PubMed Central. Intracranial Pressure Monitoring Systems in Children with Traumatic Brain Injury: Combining Therapeutic and Diagnostic Tools The reason is straightforward: when the EVD is open and draining, it is actively lowering the pressure it is trying to measure. This means EVDs can underestimate true intracranial pressure during active drainage.
Children Versus Adults
VP shunt performance differs substantially between pediatric and adult patients. In a long-term follow-up study, the revision rate in children under 17 was about 78%, compared to roughly 33% in adults.14PubMed. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus Several factors drive this gap. Children’s growing bodies mean the distal catheter can migrate as the child gets taller, requiring revisions simply because the hardware is no longer long enough. Younger brains also tend to have different underlying causes of hydrocephalus, and the age at surgery, cause of hydrocephalus, and type of hydrocephalus all independently affect revision risk.
The underlying cause matters in adults, too. Among adult patients, congenital hydrocephalus and normal pressure hydrocephalus had the lowest 30-day failure rates (roughly 5% and 9%, respectively), while shunts placed after brain infections had a 30-day failure rate above 44%.15Hydrocephalus Association. Risk Factors for Ventriculoperitoneal (VP) Shunt Failure in Children and Adults That enormous range underscores how much the individual clinical situation shapes outcomes.
Normal Pressure Hydrocephalus and Shunt Response
Normal pressure hydrocephalus (NPH) is one of the most common reasons adults receive a VP shunt. It is a condition seen primarily in older adults, marked by difficulty walking, urinary incontinence, and cognitive decline, despite intracranial pressure readings that appear close to normal. Shunting can produce striking improvements in some patients, particularly in walking ability. In one series of 116 NPH patients, nearly two-thirds showed gait improvement after shunt surgery, while improvements in incontinence and cognition were less common. A shorter duration of gait symptoms before surgery predicted a better walking outcome, and patients taking cognition-enhancing medications were more likely to see improvement in cognitive or continence symptoms.16PubMed Central. Outcomes of Normal Pressure Hydrocephalus: A Case Series of 116 Patients
This pattern suggests that timing matters. The longer someone has been dealing with gait problems before being evaluated for NPH, the less likely a shunt is to restore normal walking. It is one of the clearest examples of how the decision to proceed with a VP shunt involves weighing not just surgical risk but the window of opportunity for benefit.
Endoscopic Third Ventriculostomy as an Alternative
Not every patient who needs chronic CSF diversion has to get a VP shunt. Endoscopic third ventriculostomy (ETV) is a surgical procedure in which a small opening is made in the floor of the third ventricle, creating a new internal pathway for CSF to bypass the blockage. It is considered a treatment of choice for obstructive hydrocephalus specifically because it avoids implanting a permanent foreign body.17Journal of Neurosciences in Rural Practice. Endoscopic third ventriculostomy
The advantage of ETV is that no hardware remains in the body, eliminating the ongoing risks of shunt malfunction, infection, and revision surgery. In a randomized trial comparing the two approaches in patients with hydrocephalus from tuberculous meningitis, outcomes at 30 days were comparable, leading the authors to suggest ETV as a reasonable first-line option for that population, given that it avoids the lifelong complications associated with a VP shunt.18PubMed Central. Comparison of ventriculoperitoneal shunt versus endoscopic third ventriculostomy in managing hydrocephalus due to tuberculous meningitis: a randomized controlled trial with a 30-day follow-up ETV does not work for all types of hydrocephalus, however. It is best suited for cases where there is a clear obstruction within the ventricular system. In communicating hydrocephalus, where the blockage lies outside the ventricles, ETV is less effective and a VP shunt remains the standard approach.
The Financial Weight of Shunt Failure
VP shunt failure is not just a medical problem; it is a financial one. In a study examining the costs of shunt failure episodes in pediatric patients, the median total cost per failure was roughly $5,400, but infections were dramatically more expensive, with a median reimbursement of nearly $24,000 compared to about $3,700 for simple obstructions. Caregivers with private insurance reported higher out-of-pocket costs than those with public insurance.19PubMed Central. The economic impact of ventriculoperitoneal shunt failure Given that many patients experience multiple revisions over a lifetime, especially children, the cumulative financial burden can be substantial.
Living with a VP Shunt
The day-to-day experience of having a VP shunt extends well beyond the surgical recovery period. In survey-based research, a large proportion of shunt recipients reported anxiety about accidentally bumping or dislodging their shunt system. This fear led many people to avoid routine activities, including sleeping on the side of the head where the shunt was placed, exercising, playing sports, spending time outdoors, and even wearing hats or glasses. Generalized anxiety and hypervigilance about the shunt site were common themes.20Journal of Craniofacial Surgery. The Impact of Hydrocephalus Shunt Devices on Quality of Life For a device that is supposed to be a long-term solution, this level of ongoing psychological burden is worth acknowledging. It is a dimension that clinical discussions often underemphasize.
Emerging Monitoring Technology
One of the most frustrating aspects of VP shunt management is the inability to check whether the device is working without a trip to the hospital and imaging studies. Researchers are developing implantable pressure sensors that could change this. A prototype continuous intracranial pressure monitor with Bluetooth connectivity has been tested, transmitting pressure readings to a mobile phone application. In bench testing, the device achieved accuracy within about 2 mmHg at normal and mildly elevated pressure ranges and could simulate common failure scenarios like proximal or distal catheter blockage and valve malfunction.21PubMed Central. Implantable Intracranial Pressure Sensor with Continuous Bluetooth Transmission via Mobile Application If this kind of technology reaches clinical use, it could allow patients and their doctors to catch shunt problems before symptoms become dangerous, closing one of the biggest gaps in current shunt care.